These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 15579164)

  • 1. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophin-3 null mutant mice display a postnatal motor neuropathy.
    Woolley AG; Sheard PW; Duxson MJ
    Eur J Neurosci; 2005 Apr; 21(8):2100-10. PubMed ID: 15869506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.
    Gibson HE; Reim K; Brose N; Morton AJ; Jones S
    Eur J Neurosci; 2005 Oct; 22(7):1701-12. PubMed ID: 16197510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.
    Khedraki A; Reed EJ; Romer SH; Wang Q; Romine W; Rich MM; Talmadge RJ; Voss AA
    J Neurosci; 2017 Aug; 37(34):8077-8091. PubMed ID: 28724748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.
    Hernández-Espinosa D; Morton AJ
    Brain Res Bull; 2006 May; 69(6):669-79. PubMed ID: 16716837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
    Glynn D; Reim K; Brose N; Morton AJ
    Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
    Ariano MA; Cepeda C; Calvert CR; Flores-Hernández J; Hernández-Echeagaray E; Klapstein GJ; Chandler SH; Aronin N; DiFiglia M; Levine MS
    J Neurophysiol; 2005 May; 93(5):2565-74. PubMed ID: 15625098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves.
    Panaite PA; Gantelet E; Kraftsik R; Gourdon G; Kuntzer T; Barakat-Walter I
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):763-72. PubMed ID: 18648326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice.
    Bolivar VJ; Manley K; Messer A
    Brain Res; 2004 Apr; 1005(1-2):29-35. PubMed ID: 15044061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
    Pallier PN; Drew CJ; Morton AJ
    Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice.
    Petersén A; Stewénius Y; Björkqvist M; Gisselsson D
    BMC Cell Biol; 2005 Sep; 6():34. PubMed ID: 16159402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
    Crocker SF; Costain WJ; Robertson HA
    Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
    Freeman W; Morton AJ
    Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.
    Klapstein GJ; Levine MS
    J Neurophysiol; 2005 Feb; 93(2):758-65. PubMed ID: 15371492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
    Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
    Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice.
    Li ZF; Wu X; Jiang Y; Liu J; Wu C; Inagaki M; Izawa I; Mizisin AP; Engvall E; Shelton GD
    J Neurol Sci; 2008 Jan; 264(1-2):77-86. PubMed ID: 17854834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.
    Josefsen K; Nielsen MD; Jørgensen KH; Bock T; Nørremølle A; Sørensen SA; Naver B; Hasholt L
    J Neuroendocrinol; 2008 Feb; 20(2):165-72. PubMed ID: 18034868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease.
    Ang ET; Schäfer R; Baltensperger R; Wernig A; Celio M; Oliver SS
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):281-93. PubMed ID: 20142762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.